GOLDMAN SACHS GROUP INC - CARDIOL THERAPEUTICS INC ownership

CARDIOL THERAPEUTICS INC's ticker is CRTPF and the CUSIP is 14161Y200. A total of 34 filers reported holding CARDIOL THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CARDIOL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$21,033
+0.6%
23,5000.0%0.00%
Q2 2023$20,915
+74.5%
23,500
-4.5%
0.00%
Q1 2023$11,988
-76.8%
24,600
-75.8%
0.00%
Q4 2022$51,765
-48.2%
101,500
+54.7%
0.00%
Q1 2022$100,000
-57.1%
65,600
-48.0%
0.00%
Q4 2021$233,000
+194.9%
126,100
+560.2%
0.00%
Q3 2021$79,00019,1000.00%
Other shareholders
CARDIOL THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
MMCAP International Inc. SPC 3,253,400$4,978,0000.29%
Vident Investment Advisory, LLC 126,157$195,0000.01%
Marble Harbor Investment Counsel, LLC 28,900$44,0000.01%
Private Ocean, LLC 20,651$32,0000.00%
Belvedere Trading LLC 80,200$146,0000.00%
COMMONS CAPITAL, LLC 2,500$4,0000.00%
Robertson Stephens Wealth Management, LLC 27,855$42,0000.00%
VALLEY NATIONAL ADVISERS INC 5,000$8,0000.00%
Mirae Asset Global Investments Co., Ltd. 1,388,836$2,146,0000.00%
Belvedere Trading LLC 16,010$29,0000.00%
View complete list of CARDIOL THERAPEUTICS INC shareholders